A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help ...

Perspective from Davidson H. Hamer, MD The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ease dengue virus symptoms when ...